iBio
IBIO
#10074
Rank
HK$0.21 B
Marketcap
HK$9.34
Share price
-6.25%
Change (1 day)
-53.65%
Change (1 year)

iBio (IBIO) - Cash on Hand

Cash on Hand as of June 2025 : HK$66.8 Million

According to iBio's latest financial reports the company has HK$66.8 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

iBio - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30HK$0.11 B229.24%
2023-06-30HK$33.7 M-87.19%
2022-06-30HK$0.26 B-65.06%
2021-06-30HK$0.75 B76.27%
2020-06-30HK$0.42 B1136.81%
2019-06-30HK$34.53 M-72.38%
2018-06-30HK$0.12 B98.06%
2017-06-30HK$63.14 M-64.64%
2016-06-30HK$0.17 B142.68%
2015-06-30HK$73.58 M164.49%
2014-06-30HK$27.82 M-18.73%
2013-06-30HK$34.23 M-21.53%
2012-06-30HK$43.62 M97.17%
2011-06-30HK$22.12 M212.22%
2010-06-30HK$7.08 M-12%
2009-06-30HK$8.05 M5334.94%
2008-06-30HK$0.14 M0.65%
2007-06-30HK$0.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Genocea Biosciences
GNCA
HK$0.15 B 134.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.91 B 2,760.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.49 B 216,189.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$2.10 B 3,048.54%๐Ÿ‡บ๐Ÿ‡ธ USA